Aarti Pharmalabs received approvals to commence operations at its greenfield facility with scalable reactor capacity.

• Phase 1 offers 440 kL reactor capacity with 63 reactors, supporting large-scale pharmaceutical manufacturing operations.
• The 80-acre greenfield facility is designed for scalability, potentially expanding capacity 810 times in the future.
• Aarti Pharmalabs is a global leader in APIs, intermediates, NCEs, and xanthine derivatives manufacturing from India.